UK's Hikma shares plunge on weak sales forecast

Hikma Pharmaceuticals

26/02/2026 08:25

** Shares of British drugmaker Hikma Pharmaceuticals HIK.L fell 17.4% to 1,364p - its lowest since Nov 2022

** Co forecast slower annual revenue growth, withdrew its medium-term targets, and said CEO Said Darwazah would step down as executive chairman to focus on turning around the drugmaker

** YTD stock has gained ~6%

(Reporting by Neeshita Beura in Bengaluru)

((Neeshita.Beura@thomsonreuters.com))